Industry news round-up: updates from September 2023
Discover what’s been happening this month in our regular monthly column, where we summarize a selection of key industry developments that took place in September 2023.
Truveta and Mathematica announce new partnership to deploy real-world data to advance public health and health equity
New partnership combines Truveta’s real-world data with Mathematica’s expertise in public health policy and data analytics to advance public health outcomes, surveillance and equity.
OM1 expands real-world evidence in dermatology by launching a dataset for hidradenitis suppurativa
OM1 announces addition of a dataset for hidradenitis suppurativa to its dermatology network of enriched real-world data, expanding real-world evidence in dermatology.
Target RWE real-world data registry for eosinophilic gastrointestinal disorders passes 1000 patient milestone
Target RWE announces that enrollment to its real-world data registry to advance real-world evidence in eosinophilic gastrointestinal disorders has surpassed 1000 contributors.
FDA adds real-world evidence to list of approved confirmatory evidence in new draft guidance
The FDA draft guidance, called ‘Demonstrating Substantial Evidence of Effectiveness Based on One Adequate and Well-Controlled Clinical Investigation and Confirmatory Evidence,’ demonstrates the agency’s commitment to exploring new types of evidence as innovative therapies evolve.
Peterson Health Technology Institute launches new assessment framework for digital health technologies
In partnership with the Institute for Clinical and Economic Research, the Peterson Health Technology Institute has released a new framework towards evaluating whether innovative healthcare technologies improve health care and lower costs.
OM1 launches curated real-world dataset for Parkinson’s disease to further neuroscience real-world evidence
OM1 expands its research-grade Mental Health and Neuroscience Real-World Data Network with a Parkinson’s disease curated dataset.
Flatiron Health and FDA renew research collaboration to advance the use of real-world evidence in oncology
Flatiron Health and FDA renew research collaboration over five years to explore real-world data study design and analytic methods in oncology.
International health technology assessment collaboration welcomes two new members
As announced by NICE, New Zealand’s Pharmac and Quebec’s INESS have joined six other health technology assessment bodies from across the UK, Australia and Canada.
HealthVerity launches expertly curated real-world dataset in chronic kidney disease
The new Chronic Kidney Disease Masterset adds to its series of integrated multisource real-world datasets developed in collaboration with Aetion to advance research in this area.
Aetion launches SURF screening tool to determine suitability of using real-world evidence to support effectiveness claims in FDA regulatory applications
The screening tool developed by Aetion, denoted with the acronym SURF, aims to assist sponsors in assessing the feasibility of using real-world data (RWD) to provide evidence supporting an effectiveness claim in US FDA product applications.
Register for our webinar with speakers from Aetion to learn more about the SURF screening tool.
